NZ541781A - Novel compositions containing fentanyl - Google Patents

Novel compositions containing fentanyl

Info

Publication number
NZ541781A
NZ541781A NZ541781A NZ54178104A NZ541781A NZ 541781 A NZ541781 A NZ 541781A NZ 541781 A NZ541781 A NZ 541781A NZ 54178104 A NZ54178104 A NZ 54178104A NZ 541781 A NZ541781 A NZ 541781A
Authority
NZ
New Zealand
Prior art keywords
formulation
formulation according
fentanyl
polar organic
organic solvent
Prior art date
Application number
NZ541781A
Other languages
English (en)
Inventor
Calvin Ross
Clive Booles
Alistair Campbell
Original Assignee
Arakis Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB0305579.5A external-priority patent/GB0305579D0/en
Application filed by Arakis Ltd filed Critical Arakis Ltd
Publication of NZ541781A publication Critical patent/NZ541781A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4468—Non condensed piperidines, e.g. piperocaine having a nitrogen directly attached in position 4, e.g. clebopride, fentanyl
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Anesthesiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NZ541781A 2003-03-11 2004-03-11 Novel compositions containing fentanyl NZ541781A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0305579.5A GB0305579D0 (en) 2003-03-11 2003-03-11 Pharmaceutical compositions
GB0328023A GB2399286A (en) 2003-03-11 2003-12-03 Sub-lingual fentanyl formulation
PCT/GB2004/001037 WO2004080382A2 (en) 2003-03-11 2004-03-11 Novel compositions containing fentanyl

Publications (1)

Publication Number Publication Date
NZ541781A true NZ541781A (en) 2008-04-30

Family

ID=32992592

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ541781A NZ541781A (en) 2003-03-11 2004-03-11 Novel compositions containing fentanyl

Country Status (10)

Country Link
EP (1) EP1608372A2 (de)
JP (1) JP2006519770A (de)
KR (1) KR20050115276A (de)
AU (1) AU2004218876B2 (de)
BR (1) BRPI0408209A (de)
CA (1) CA2516338A1 (de)
MX (1) MXPA05009602A (de)
NO (1) NO20054172L (de)
NZ (1) NZ541781A (de)
WO (1) WO2004080382A2 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5577021B2 (ja) * 2005-02-17 2014-08-20 アボット・ラボラトリーズ 動物における障害を治療および予防するための薬剤組成物の経粘膜投与
GB0514043D0 (en) * 2005-07-08 2005-08-17 Arakis Ltd Fentanyl formulation
DK1976521T3 (en) 2006-01-25 2015-04-27 Insys Therapeutics Inc Sublingual fentanyl spray
PT2180844T (pt) 2007-08-02 2018-04-06 Insys Dev Co Inc Nebulizador sub-lingual de fentanilo
GB2476494A (en) * 2009-12-24 2011-06-29 Norwich Pharma Technologies Ltd Formulation for the sublingual delivery of sufentanil

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2201358C (en) * 1994-09-30 2004-06-08 Jurgen Regenold Pharmaceutical composition
US20030185761A1 (en) * 1997-10-01 2003-10-02 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing drugs for treating pain
EP2042161A1 (de) * 1997-10-01 2009-04-01 Novadel Pharma Inc. Treibmittelfreie Sprayzusammensetzung enthaltend ein Antiemetikum
SE9803239D0 (sv) * 1998-09-24 1998-09-24 Diabact Ab Composition for the treatment of acute pain
US6849263B2 (en) * 1998-12-21 2005-02-01 Generex Pharmaceutical Incorporated Pharmaceutical compositions for buccal delivery of pain relief medications
WO2000047203A1 (en) * 1999-02-12 2000-08-17 Mqs, Inc. Formulation and system for intra-oral delivery of pharmaceutical agents
AU2001262992A1 (en) * 2000-05-10 2002-02-18 University Of Kentucky Research Foundation System and method for intranasal administration of opioids
DE10064219B9 (de) * 2000-12-22 2009-02-12 Nasalis Pain Relief International Gmbh Neue Fentanyl und/oder dessen Derivate enthaltende pharmazeutische Zusammensetzung zur nasalen Anwendung

Also Published As

Publication number Publication date
CA2516338A1 (en) 2004-09-23
WO2004080382A3 (en) 2005-03-24
MXPA05009602A (es) 2005-11-08
BRPI0408209A (pt) 2006-02-14
WO2004080382A2 (en) 2004-09-23
NO20054172D0 (no) 2005-09-07
AU2004218876B2 (en) 2007-08-02
JP2006519770A (ja) 2006-08-31
AU2004218876A1 (en) 2004-09-23
EP1608372A2 (de) 2005-12-28
KR20050115276A (ko) 2005-12-07
NO20054172L (no) 2005-10-06

Similar Documents

Publication Publication Date Title
US20060062812A1 (en) Novel compositions
JP5630877B2 (ja) 舌下フェンタニルスプレー
US20090270438A1 (en) Novel compositions and formulations
US20070209660A1 (en) Intranasal Opioid Compositions, Delivery Devices and Methods of Using Same
EP1904032B1 (de) Fentanyl-formulierung mit einem essentiellen öl
CZ281931B6 (cs) Sulfát 3-/2-(dimethylamino)ethyl-N-methyl-1H-indol-5-methansulfonamidu a farmaceutické prostředky s jeho obsahem
CA2666581A1 (en) Buprenorphine-containing non-pressurised spray composition for transmucosal administration
EA005179B1 (ru) Стабильные фармацевтические препараты в виде растворов для дозированных ингаляторов под давлением
AU2003215597A1 (en) Aerosol formulations for pulmonary administration of medicaments to produce a systemic effect
CA2673049C (en) Stable anti-nausea oral spray formulations and methods
US8802058B2 (en) Pharmaceutical compositions and methods for administering the same
KR20070007257A (ko) 습기 민감성 의약용 기-계량된 건조 분말 흡입기
WO2009127878A1 (en) A liquid spray solution comprising buprenorphine, ethanol and an antioxidant
AU2004218876B2 (en) Novel compositions containing fentanyl
ZA200506248B (en) Novel compositions containing fentanyl
US20090180969A1 (en) Pharmaceutical formulation comprising an anticholinergic drug
AU2020340617A1 (en) Pharmaceutical composition
KR20130142990A (ko) 오피오이드의 설하 전달용 약제 조성물

Legal Events

Date Code Title Description
RENW Renewal (renewal fees accepted)
PSEA Patent sealed